Permeability of blood-brain barrier to various sized molecules

1985 ◽  
Vol 248 (5) ◽  
pp. H712-H718 ◽  
Author(s):  
W. G. Mayhan ◽  
D. D. Heistad

We studied disruption of the blood-brain barrier (BBB) by acute hypertension and a hyperosmolar solution. The goals were to determine whether 1) disruption of the BBB occurs primarily in arteries, capillaries, or veins, and 2) transport of different-sized molecules is homogeneous or size dependent. Sprague-Dawley rats were studied using intravital fluorescent microscopy of pial vessels and fluorescein-labeled dextrans (FITC-dextran, mol wt = 70,000, 20,000, and 4,000 daltons). The site of disruption was determined by the appearance of microvascular leaky sites. Transport of different-sized molecules was calculated from clearance of FITC-dextran. During gradual hypertension and osmotic disruption, all leaky sites were venular. Rapid hypertension produced venular leaky sites and, in some experiments, diffuse arteriolar extravasation of FITC-dextran. Clearance of different-sized molecules was homogeneous during acute hypertension. In contrast, clearance of molecules during osmotic disruption was size dependent. The findings suggest that 1) venules and veins are the primary sites of disruption following acute hypertension and a hyperosmolar solution; 2) transport of different-sized molecules is homogeneous following acute hypertension, which suggests a vesicular mechanism; and 3) transport following hyperosmolar disruption is size dependent, which suggests that hyperosmolar disruption may involve formation of pores as well as vesicular transport.

1986 ◽  
Vol 251 (6) ◽  
pp. H1171-H1175 ◽  
Author(s):  
W. G. Mayhan ◽  
F. M. Faraci ◽  
D. D. Heistad

The purpose of this study was to examine hemodynamic mechanisms of protection of the blood-brain barrier in the brain stem during acute hypertension. We used a new method to examine the microcirculation of the brain stem. Intravital fluorescent microscopy and fluorescein-labeled dextran were used to evaluate disruption of the blood-brain barrier during acute hypertension in rats. During control conditions, pressure (servo null) in arterioles (60 microns in diameter) was 50 +/- 2% (mean +/- SE) of systemic arterial pressure in the cerebrum and 67 +/- 1% of systemic arterial pressure in the brain stem (P less than 0.05 vs. cerebrum). In the cerebrum, pial venous pressure increased from 7 +/- 1 to 25 +/- 2 mmHg during acute hypertension, and there was marked disruption of the blood-brain barrier in venules (26 +/- 2 leaky sites). In contrast, in the brain stem, pial venous pressure increased from 4 +/- 1 to only 8 +/- 1 mmHg (P less than 0.05 vs. cerebrum), and there was minimal disruption of the blood-brain barrier in venules (1.5 +/- 0.6 leaky sites, P less than 0.05 vs. cerebrum). During acute hypertension, increases in blood flow (microspheres) were less in brain stem than in cerebrum. The findings suggest distribution of vascular resistance differs in the brain stem and cerebrum under control conditions, whereas large arteries account for a greater fraction of resistance in cerebrum; pial venous pressure increases less in brain stem than cerebrum during acute hypertension, so that the blood-brain barrier is protected.(ABSTRACT TRUNCATED AT 250 WORDS)


1984 ◽  
Vol 61 (4) ◽  
pp. 674-678 ◽  
Author(s):  
Melvin K. Spigelman ◽  
Rosario A. Zappulla ◽  
James Johnson ◽  
Stanley J. Goldsmith ◽  
Leonard I. Malis ◽  
...  

✓ The intracarotid infusion of the anti-neoplastic compound, etoposide, has been shown to exert a dose-dependent effect on blood-brain barrier (BBB) permeability. Etoposide, however, is formulated in a complex solvent solution containing alcohol, Tween 80, polyethylene glycol 300, and citric acid. To investigate the contribution of the solvent solution to BBB disruption, the authors studied Sprague-Dawley rats after the internal carotid artery infusion of the solvent solution with and without the addition of etoposide. Experiments were performed at four doses of drug and/or solvent. Disruption of the BBB was evaluated qualitatively by the appearance of the systemically administered dye, Evans blue, in the cerebral hemispheres and quantitatively by the ratio of gamma counts of the technetium-labeled chelate of diethylenetriaminepentaacetic acid (99mTc-DTPA) in the ipsilateral:contralateral hemisphere. Significant barrier opening was obtained in all four groups of animals infused with solvent plus etoposide. In the corresponding groups of rats infused with the solvent solution alone, BBB disruption was markedly lower. Only in the group infused with the largest dose of solvent was the hemispheric ratio of 99mTc-DTPA significantly different from saline-infused animals. Each of the groups with solvent plus etoposide had 99mTc-DTPA ratios significantly different from the control group. Intracarotid infusion and subsequent BBB disruption were well tolerated by the animals receiving either solvent alone or solvent and etoposide. Disruption of the BBB secondary to the intracarotid infusion of etoposide is primarily caused by the drug itself and not by the solvent solution.


Author(s):  
John P. Petrali ◽  
Donald M. Maxwell ◽  
Kenneth R. Mills

Soman, an organophosphorous irreversible inhibitor of acetylcholinesterase was studied for its effect on the rat blood- brain barrier (BBB) during the first 24 hours of intoxication. Young adult male Sprague-Dawley rats injected with Evans blue dye (1. V. 2ml/kg of a 2% solution) and surviving a subsequent single convulsive dose of Soman (0.9 LD50) presented focal and diffuse penetration of dye in areas of brain normally considered protected by the BBB. Invasion was widest during the the first hour, when signs of excitation, respiratory distress, and convulsions peaked and was absent at 24 hours. During this time period, acetylcholinesterase inhibition, as measured by enzyme assay, persisted in brain and blood at 10 percent and 6 percent of control values respectively. Brains of nonconvulsing animals and animals pretreated with sodium pentobarbital (45mg/kg) or with diazepam (10 mg/kg) were free of extravasated dye.


1990 ◽  
Vol 258 (6) ◽  
pp. H1735-H1738 ◽  
Author(s):  
W. G. Mayhan

The goal of this study was to determine whether the susceptibility of the blood-brain barrier to disruption during acute hypertension is altered in aged rats. Intravital fluorescent microscopy and fluorescein-labeled albumin were used to evaluate disruption of the blood-brain barrier during acute hypertension in adult Wistar rats (6-8 mo) and aged Wistar rats (24-26 mo). Permeability of the blood-brain barrier albumin and by counting the number of microvascular leaky sites under control conditions and during acute arterial hypertension in adult and aged rats. Pressure in pial venules, which are the primary site of disruption of the blood-brain barrier during acute hypertension, and in pial arterioles was measured using a servo-null device. In adult rats, when systemic arterial pressure was increased from 124 +/- 5 (means +/- SE) to 190 +/- 5 mmHg, clearance of albumin increased from 0.10 +/- 0.05 to 1.64 +/- 0.76 X 10(-6) ml/s. In aged rats, when systemic arterial pressure was increased from 116 +/- 4 to 185 +/- 3 mmHg, clearance of albumin increased from 0.10 +/- 0.03 to 1.56 +/- 0.49 X 10(-6) ml/s. Increases in pial venular pressure and pial arteriolar pressure also were similar in adult and aged rats. Thus the findings suggest that the susceptibility of the blood-brain barrier to disruption during acute hypertension is similar in adult and aged rats.


Sign in / Sign up

Export Citation Format

Share Document